Abstract
Over the past 15 years, patients with a myriad of pulmonary conditions have been diagnosed and treated with new technologies developed for the pulmonary community. Advanced diagnostic and therapeutic procedures once performed in an operating theater under general anesthesia are now routinely performed in a bronchoscopy suite under moderate sedation with clinically meaningful improvements in outcome. With the miniaturization of scopes and instruments, improvements in optics, and creative engineers, a host of new devices has become available for clinical testing and use. A growing community of pulmonologists is doing comparative effectiveness trials that test new technologies against the current standard of care. While more research is needed, it seems reasonable to provide an overview of pulmonary procedures that are in various stages of development, testing, and practice at this time. Five areas are covered: navigational bronchoscopy, endobronchial ultrasound, endoscopic lung volume reduction, bronchial thermoplasty, and pleural procedure. Appropriate training for clinicians who wish to provide these services will become an area of intense scrutiny as new skills will need to be acquired to ensure patient safety and a good clinical result.
Original language | English (US) |
---|---|
Pages (from-to) | 1636-1644 |
Number of pages | 9 |
Journal | CHEST |
Volume | 142 |
Issue number | 6 |
DOIs | |
State | Published - Dec 2012 |
Funding
Financial/nonfinancial disclosures: The authors have reported to CHEST the following conflicts: Dr Silvestri has received grant funding from Olympus America Inc, Bronchus, and Boston Scientific Corporation and has performed consulting services for Olympus America Inc and Bronchus in amounts < the following conflicts: Dr Silvestri has received grant funding from Olympus America Inc, Bronchus, and Boston Scientific Corporation and has performed consulting services for Olympus America Inc and Bronchus in amounts <$10,000. Dr Feller-Kopman has been a consultant for Innovative Pulmonary Solutions, Inc and CareFusion Corporation and his affiliation, the Division of Pulmonary and Critical Care Medicine, has received educational grants from SuperDimension, Olympus America Inc, and Boston Scientific Corporation. Dr Chen has received honoraria from Olympus America Inc for serving on an advisory panel and from Boston Scientific Corporation for serving on the speaker's bureau and received education grant support for CME coursework from Olympus America Inc and Veran Medical Technologies. Dr Wahidi has received educational grants from Boston Scientific Corporation and consulted with Olympus America Inc. Dr Yasufuku has received educational and research grants from Olympus Medical Systems Corporation and served as a consultant for Intuitive Surgical, Inc; Olympus America Inc; Covidien; and Novadaq Technologies Inc. Dr Ernst has served as a consultant for Boston Scientific Corporation, Olympus America Inc, Covidien, PneumRx, Pulmonx, UpTake, Innovative Pulmonary Solutions, Aeris Therapeutics, and Veran Medical Technologies.0,000. Dr Feller-Kopman has been a consultant for Innovative Pulmonary Solutions, Inc and CareFusion Corporation and his affiliation, the Division of Pulmonary and Critical Care Medicine, has received educational grants from SuperDimension, Olympus America Inc, and Boston Scientific Corporation. Dr Chen has received honoraria from Olympus America Inc for serving on an advisory panel and from Boston Scientific Corporation for serving on the speaker's bureau and received education grant support for CME coursework from Olympus America Inc and Veran Medical Technologies. Dr Wahidi has received educational grants from Boston Scientific Corporation and consulted with Olympus America Inc. Dr Yasufuku has received educational and research grants from Olympus Medical Systems Corporation and served as a consultant for Intuitive Surgical, Inc; Olympus America Inc; Covidien; and Novadaq Technologies Inc. Dr Ernst has served as a consultant for Boston Scientific Corporation, Olympus America Inc, Covidien, PneumRx, Pulmonx, UpTake, Innovative Pulmonary Solutions, Aeris Therapeutics, and Veran Medical Technologies.
ASJC Scopus subject areas
- Critical Care and Intensive Care Medicine
- Cardiology and Cardiovascular Medicine
- Pulmonary and Respiratory Medicine